Bill Hearl
Rockville, MD (USA)
Role(s):
C-Level Executive (CEO, CFO, etc.)
Immunomic Therapeutics, Inc
Find More Startups
Startup
Location:
Rockville
Industry:
Bio-Technology
Year Founded:
2006
Number Employees:
1-10 people
Business Stage:
Growth (not profitable)
Entity Type:
"C" Corporation
Description:
Immunomic Therapeutics is pioneering next generation vaccines that will transform human health. The Company's products are based on the innovative and patented LAMP-vax Technology platform which has been shown to be responsive in human clinical studies in cancer and allergy and in animal studies in infectious diseases. Our lead product, JRC-LAMP-vax addresses the multi-billion dollar Japanese red cedar market which is one of the largest allergy opportunities in the world. Our second product in development, ARA-LAMP-vax, provides a potential long term and safe solution to peanut allergy. Both products set the foundation for continued long term growth and value as the represent only a small fraction of the opportunities in just the allergy market. Our commitment to our investors and to our pharma partners is to deliver high value products supported by a strong business case and rigorous scientific data.